A maternal history of Graves' disease places the fetus at risk for thy
rotoxicosis in utero via the placental transfer of thyroid-stimulating
immunoglobulins. Methods for prediction of fetal hyperthyroidism are
available, but are not widely used. Clinical assessment of fetal thyro
id status by monitoring of fetal heart rate and growth may be inaccura
te. This raises some uncertainty in the initial diagnosis of fetal thy
rotoxicosis and complicates the assessment of fetal response to matern
al propylthiouracil therapy. A case illustrating these pitfalls in the
diagnosis and management of fetal hyperthyroidism is presented. The c
ondition was correctly diagnosed, but treatment based on fetal heart r
ate resulted in biochemical hypothyroidism in the infant at birth. Cur
rent recommendations for diagnosis and treatment of fetal hyperthyroid
ism are reviewed along with recent developments in the field. A modifi
ed approach is proposed.